{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:00:43Z","timestamp":1778079643718,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.radonc.2020.08.005","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T11:27:05Z","timestamp":1597318025000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer"],"prefix":"10.1016","volume":"151","author":[{"given":"Sarah Nicole","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5111-3713","authenticated-orcid":false,"given":"Alvin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0937-0468","authenticated-orcid":false,"given":"Eric","family":"Berthelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-2302","authenticated-orcid":false,"given":"Eric","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonn","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3177-0684","authenticated-orcid":false,"given":"Yaling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2020.08.005_b0005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2020.08.005_b0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.oraloncology.2014.09.011","article-title":"Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals On behalf of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA","volume":"50","author":"Beachler","year":"2014","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.radonc.2020.08.005_b0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.radonc.2020.08.005_b0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","article-title":"Cervical cancer control in HIV-infected women: past, present and future","volume":"21","author":"Ghebre","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.radonc.2020.08.005_b0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1586\/era.12.159","article-title":"Immunosuppression and risk of cervical cancer","volume":"13","author":"Dugu\u00e9","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.radonc.2020.08.005_b0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/jcm4020260","article-title":"HPV carcinomas in immunocompromised patients","volume":"4","author":"Reusser","year":"2015","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2020.08.005_b0035","first-page":"34","article-title":"HIV- positive anal cancer: an update for the clinician","volume":"1","author":"Dandapani","year":"2010","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.radonc.2020.08.005_b0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"van Leeuwen","year":"2007","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.radonc.2020.08.005_b0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/CEJ.0000000000000432","article-title":"Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach","volume":"28","author":"Bogani","year":"2019","journal-title":"Eur J Cancer Prev."},{"key":"10.1016\/j.radonc.2020.08.005_b0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Pompei","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.radonc.2020.08.005_b0055","doi-asserted-by":"crossref","unstructured":"Greenberg JA, Hohmann SF, Hall JB, Kress JP, David MZ. Validation of a method to identify immunocompromised patients with severe sepsis in administrative databases, Ann Am Thorac Soc 2016;13:253\u201358","DOI":"10.1513\/AnnalsATS.201507-415BC"},{"key":"10.1016\/j.radonc.2020.08.005_b0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"AProportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Gray","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.radonc.2020.08.005_b0065","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/sim.3150","article-title":"A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003","volume":"27","author":"Austin","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2020.08.005_b0070","unstructured":"Yang D, Dalton JE. A unified approach to measuring the effect size between two groups using SAS\u00ae. SAS Global Forum, vol. 1, 2012."},{"key":"10.1016\/j.radonc.2020.08.005_b0075","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2020.08.005_b0080","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0194599818808511","article-title":"Immunosuppression impact on head and neck cutaneous squamous cell carcinoma: a systematic review with meta-analysis","volume":"160","author":"Elghouche","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2020.08.005_b0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ijc.25080","article-title":"Immunosuppressive disorders and risk of anal squamous cell carcinoma: s nationwide cohort study in Denmark, 1978-2005","volume":"127","author":"Sunesen","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2020.08.005_b0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.amjsurg.2019.08.011","article-title":"Outcomes in immunosuppressed anal cancer patients","volume":"219","author":"Bingmer","year":"2020","journal-title":"Am J Surg"},{"issue":"9","key":"10.1016\/j.radonc.2020.08.005_b0095","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/ibd\/izy096","article-title":"Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study","volume":"24","author":"Nissen","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.radonc.2020.08.005_b0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cgh.2015.09.041","article-title":"Increased risk of oral cancer in patients with inflammatory bowel diseases","volume":"14","author":"Katsanos","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.radonc.2020.08.005_b0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0194599818774756","article-title":"HPV-positive oropharyngeal squamous cell carcinoma among patients taking adalimumab for autoimmune disorders","volume":"159","author":"Farquhar","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2020.08.005_b0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00007890-199902150-00014","article-title":"Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis","volume":"67","author":"Duvoux","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.radonc.2020.08.005_b0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hed.10055","article-title":"Squamous cell carcinoma of the head and neck in solid organ transplant recipients","volume":"24","author":"Preciado","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2020.08.005_b0120","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00005537-200008000-00006","article-title":"Head and Neck Cancer in Cardiothoracic Transplant Recipients:","volume":"110","author":"Pollard","year":"2000","journal-title":"The Laryngoscope"},{"key":"10.1016\/j.radonc.2020.08.005_b0125","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijrobp.2015.12.145","article-title":"Patient immunosuppression and the association with cancer-specific outcomes after treatment of squamous cell carcinoma of the oropharynx","volume":"94","author":"Margalit","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2020.08.005_b0130","article-title":"Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy","volume":"7","author":"Canning","year":"2019","journal-title":"Front Media S.A."},{"key":"10.1016\/j.radonc.2020.08.005_b0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.oraloncology.2017.02.005","article-title":"Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck","volume":"67","author":"Hanna","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2020.08.005_b0140","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"17","author":"Mandal","year":"2016","journal-title":"JCI Insight"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020307234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814020307234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:12:29Z","timestamp":1759122749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814020307234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"alternative-id":["S0167814020307234"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2020.08.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2020.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}